Travail publié

Rechercher

COVID-19 dans les populations sans abri : défis et opportunités uniques.

Vulnerable populations, such as those in urban Vancouver, are both more susceptible to COVID-19 and less able to implement recommended...

Glécaprévir/pibrentasvir+sofosbuvir : Une stratégie de retraitement optimale dans le cadre VHC NS5A

Some individuals do not achieve a cure of their hepatitis C virus (HCV) infection due to non-adherence or resistance associated substitution

Faible taux de réinfection parmi une cohorte de personnes qui utilisent des médicaments traités avec

Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in...

Sofosbuvir et velpatasvir dans le traitement de l'hépatite C chronique

Advances in hepatitis C virus (HCV) treatment led to the development of highly effective all oral direct acting antiviral regimens.

COVID-19 et sports